Cellebrite DI Ltd. CLBT
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | 131.14M | 128.82M | 126.03M | 113.28M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 131.14M | 128.82M | 126.03M | 113.28M | |
| Cost of Revenue | 25.21M | 19.69M | 20.31M | 17.68M | |
| Gross Profit | 105.93M | 109.13M | 105.72M | 95.60M | |
| SG&A Expenses | 63.02M | 58.46M | 58.60M | 52.57M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 124.19M | 108.02M | 107.04M | 98.86M | |
| Operating Income | 6.95M | 20.81M | 18.99M | 14.42M | |
| Income Before Tax | 11.19M | 26.27M | 24.29M | 20.79M | |
| Income Tax Expenses | 4.82M | 5.01M | 4.10M | 1.32M | |
| Earnings from Continuing Operations | 6.37M | 21.26M | 20.19M | 19.48M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 6.37M | 21.26M | 20.19M | 19.48M | |
| EBIT | 6.95M | 20.81M | 18.99M | 14.42M | |
| EBITDA | 15.86M | 24.75M | 21.69M | 17.01M | |
| EPS Basic | 0.03 | 0.08 | 0.08 | 0.08 | |
| Normalized Basic EPS | 0.03 | 0.07 | -- | 0.05 | |
| EPS Diluted | 0.03 | 0.08 | 0.08 | 0.08 | |
| Normalized Diluted EPS | 0.03 | 0.07 | -- | 0.05 | |
| Average Basic Shares Outstanding | 247.62M | 245.28M | 243.51M | 240.36M | |
| Average Diluted Shares Outstanding | 252.79M | 251.50M | 249.72M | 248.98M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |